Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3427355
Max Phase: Preclinical
Molecular Formula: C18H21N3O2
Molecular Weight: 311.38
Molecule Type: Small molecule
Associated Items:
ID: ALA3427355
Max Phase: Preclinical
Molecular Formula: C18H21N3O2
Molecular Weight: 311.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc(N2CCN(/N=C/c3ccc(O)cc3O)CC2)c1
Standard InChI: InChI=1S/C18H21N3O2/c1-14-3-2-4-16(11-14)20-7-9-21(10-8-20)19-13-15-5-6-17(22)12-18(15)23/h2-6,11-13,22-23H,7-10H2,1H3/b19-13+
Standard InChI Key: TYMJZGJKBIKWNG-CPNJWEJPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 311.38 | Molecular Weight (Monoisotopic): 311.1634 | AlogP: 2.56 | #Rotatable Bonds: 3 |
Polar Surface Area: 59.30 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.64 | CX Basic pKa: 3.63 | CX LogP: 3.21 | CX LogD: 3.19 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.86 | Np Likeness Score: -1.02 |
1. Mayer N, Schweiger M, Melcher MC, Fledelius C, Zechner R, Zimmermann R, Breinbauer R.. (2015) Structure-activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL)., 23 (12): [PMID:25778769] [10.1016/j.bmc.2015.02.051] |
Source(1):